We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
General Motors
GM
$74.7B
| $62.4M | 0.16% |
1,872,366
+182,775
| +11% | +$6.52M |
|
127
ResMed
RMD
$28.3B
| $62.2M | 0.16% |
1,103,530
+820,916
| +290% | +$51.8M |
|
|
PPLI
128
People Inc
PPLI
$3.1B
| $61.9M | 0.16% |
4,347,167
+42,441
| +1% | +$563K |
|
129
Flowers Foods
FLO
$1.64B
| $61.5M | 0.16% |
2,907,049
+2,772,978
| +2,068% | +$62.3M |
|
130
Phillips 66
PSX
$82.9B
| $61M | 0.16% |
757,200
+34,850
| +5% | +$2.77M |
|
131
HP
HPQ
$23.5B
| $60.6M | 0.16% |
4,444,662
+1,214,434
| +38% | +$18M |
|
132
Cooper Companies
COO
$13.7B
| $60.1M | 0.16% |
1,351,728
+569,704
| +73% | +$25.7M |
|
133
Campbell Soup
CPB
$6.51B
| $59.5M | 0.15% |
1,248,014
+83,492
| +7% | +$3.9M |
|
|
TGNA
134
DELISTED
TEGNA Inc
TGNA
| $59.4M | 0.15% |
2,893,742
+1,468,141
| +103% | +$27.6M |
|
|
PF
135
DELISTED
Pinnacle Foods, Inc.
PF
| $58.6M | 0.15% |
1,286,673
-397,466
| -24% | -$16.8M |
|
|
GNC
136
DELISTED
GNC Holdings, Inc.
GNC
| $58.6M | 0.15% |
1,317,248
+100,020
| +8% | +$4.56M |
|
137
Leggett & Platt
LEG
$1.52B
| $58.2M | 0.15% |
1,195,943
-13,211
| -1% | -$617K |
|
|
TFCFA
138
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $57.9M | 0.15% |
1,778,640
+1,191,109
| +203% | +$40M |
|
|
N
139
DELISTED
Netsuite Inc
N
| $57.5M | 0.15% |
627,206
+40,780
| +7% | +$3.86M |
|
|
CA
140
DELISTED
CA, Inc.
CA
| $57M | 0.15% |
1,947,257
-210,304
| -10% | -$6.53M |
|
141
Dollar Tree
DLTR
$23.1B
| $56.7M | 0.15% |
717,855
-3,665
| -0.5% | -$290K |
|
142
McCormick & Company Non-Voting
MKC
$13.4B
| $55.7M | 0.14% |
1,376,740
+666,692
| +94% | +$25.9M |
|
143
Texas Instruments
TXN
$255B
| $55.7M | 0.14% |
1,081,402
+69,678
| +7% | +$3.84M |
|
144
Clorox
CLX
$11.6B
| $55.1M | 0.14% |
530,083
+281,747
| +113% | +$30.4M |
|
145
Idexx Laboratories
IDXX
$42.9B
| $55.1M | 0.14% |
859,017
-47,895
| -5% | -$3.32M |
|
146
Starbucks
SBUX
$118B
| $54.9M | 0.14% |
1,023,658
+611,216
| +148% | +$31M |
|
147
Ross Stores
ROST
$76.6B
| $54.7M | 0.14% |
1,124,590
+17,528
| +2% | +$881K |
|
148
Broadcom
AVGO
$1.82T
| $54.4M | 0.14% |
4,092,360
-223,620
| -5% | -$2.93M |
|
149
Brookdale Senior Living
BKD
$3.62B
| $54M | 0.14% |
1,556,771
-429,793
| -22% | -$15.8M |
|
150
Johnson & Johnson
JNJ
$634B
| $53.9M | 0.14% |
553,323
+56,435
| +11% | +$5.65M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.